Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies

SIMPLE SUMMARY: Gene expression of esophageal adenocarcinoma is highly heterogeneous. In general, these cancers have poor prognosis and unpredictable responses to chemo- and radiotherapy. Investigating expression profiles from RNA from pre-treatment biopsies are highly attractive to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoefnagel, Sanne J. M., Koemans, Willem J., Khan, Hina N., Koster, Jan, Meijer, Sybren L., van Dieren, Jolanda M., Kodach, Liudmila L., van Sandick, Johanna W., Calpe, Silvia, del Sancho-Serra, Carmen M., Correia, Ana C. P., Van Berge Henegouwen, Mark I., Gisbertz, Suzanne S., Hulshof, Maarten C. C. M., Mattioli, Sandro, Spaander, Manon C. W., Krishnadath, Kausilia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496882/
https://www.ncbi.nlm.nih.gov/pubmed/36139661
http://dx.doi.org/10.3390/cancers14184498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496882/
https://www.ncbi.nlm.nih.gov/pubmed/36139661
http://dx.doi.org/10.3390/cancers14184498

Ejemplares similares